Skip to content
10-K

Annual Report

RANI THERAPEUTICS HOLDINGS, INC. RANI

0001193125-26-126417

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 66.14K sh
Shares Diluted FY 2025 · Dec 31, 2024 28.48K sh
Capex FY 2025 · Dec 31, 2025 $88K
Capex FY 2025 · Dec 31, 2024 $268K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$18.71M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$35.5M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $9.61M
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $15M
Cash And Equivalents FY 2025 · Dec 31, 2025 $18.62M
Cash And Equivalents FY 2025 · Dec 31, 2024 $3.76M
Stockholders Equity FY 2025 · Dec 31, 2025 $33.01M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.99M
Current Liabilities FY 2025 · Dec 31, 2025 $12.67M
Current Liabilities FY 2025 · Dec 31, 2024 $19.89M
Total Liabilities FY 2025 · Dec 31, 2025 $17.11M
Total Liabilities FY 2025 · Dec 31, 2024 $33.14M
Current Assets FY 2025 · Dec 31, 2025 $53.32M
Current Assets FY 2025 · Dec 31, 2024 $29.74M
Total Assets FY 2025 · Dec 31, 2025 $58.62M
Total Assets FY 2025 · Dec 31, 2024 $36.63M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.45
Eps Diluted FY 2025 · Dec 31, 2024 −$1.05
Eps Basic FY 2025 · Dec 31, 2025 −$0.45
Eps Basic FY 2025 · Dec 31, 2024 −$1.05
Sga Expense FY 2025 · Dec 31, 2025 $19.74M
Sga Expense FY 2025 · Dec 31, 2024 $23.95M
Rd Expense FY 2025 · Dec 31, 2025 $20.21M
Rd Expense FY 2025 · Dec 31, 2024 $26.68M
Net Income FY 2025 · Dec 31, 2025 −$29.67M
Net Income FY 2025 · Dec 31, 2024 −$30.02M
Operating Income FY 2025 · Dec 31, 2025 −$38.31M
Operating Income FY 2025 · Dec 31, 2024 −$53.31M
Revenue FY 2025 · Dec 31, 2025 $1.63M
Revenue FY 2025 · Dec 31, 2024 $1.03M